Also known as آسٹیوپوروسس مینجمنٹ
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Internal Medicine Specialist
MBBS (AIMC), MD (USA), FACP (US), Diplomat American Board of Internal Medicine, Diplomat American Board of Geriatric Medicine
Internal Medicine Specialist
MBBS (AIMC), MD (USA), FACP (US), Diplomat American Board of Internal Medicine, Diplomat American Board of Geriatric Medicine
Internal Medicine Specialist
M.B.B.S, Diplomate of American Board (Internal Medicine), Diplomate of American Board (Nephrology)
Internal Medicine Specialist
M.B.B.S, Diplomate of American Board (Internal Medicine), Diplomate of American Board (Nephrology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), OJT Rheumatology, FCPS Rheumatology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), OJT Rheumatology, FCPS Rheumatology
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures